Table 2.

Significant covariates with respect to the survival and related log-rank test P-values.

Covariate	HR (95% CI for HR)	P-value
Age	1.04 (1.011–1.07)	0.006796
Gender	1.728 (0.8304–3.598)	0.1435
Stage T	0.7244 (0.2225–2.358)	0.5924
Stage N	0.943 (0.5012–1.773)	0.8546
Stage M	0.936 (0.435–2.014)	0.8656
Types of PVTT	0.518 (0.276–0.971)	0.0403
HBsAg	0.989 (0.9302–1.052)	0.7339
Child-Pugh classification	1.914 (1.036–3.537)	0.0243
ECOG	2.342 (1.232–4.453)	0.009441
AFP	1 (1)	0.06224
PLT	1 (0.9963–1.005)	0.8193
HGB	0.9783 (0.9628–0.994)	0.006954
TBIL	1.007 (0.9957–1.018)	0.2332
ALB	0.918 (0.8543–0.9865)	0.01982
ALT	0.997 (0.993–1.002)	0.2326
AST	0.999 (0.9981–1.001)	0.5197

PVTT, Portal vein tumor thrombus; HBsAg, Hepatitis B surface antigen; PS, Performance status; ECOG, Eastern Cooperative Oncology Group; AFP, Alpha–fetoprotein; PLT, Platelet; HGB, Hemoglobin; TBIL, Total bilirubin; ALB, Albumin; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase.